ProtoKinetix Inc PKTX:OTCQB

RT Quote | Exchange | USD
Last | 05/23/22 EDT
0.0301UNCH (UNCH)
52 week range
0.02 - 0.19
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0301
  • 52 Week High0.19
  • 52 Week High Date06/10/21
  • 52 Week Low0.02
  • 52 Week Low Date05/19/22

Key Stats

  • Market Cap9.18M
  • Shares Out304.83M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.42
  • YTD % Change-69.9

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0301
  • 52 Week High0.19
  • 52 Week High Date06/10/21
  • 52 Week Low0.02
  • 52 Week Low Date05/19/22
  • Market Cap9.18M
  • Shares Out304.83M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.42
  • YTD % Change-69.9

RATIOS/PROFITABILITY

  • EPS (TTM)-0.01
  • P/E (TTM)-3.25
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-2.711M
  • ROE (TTM)-556.19%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ProtoKinetix Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
ProtoKinetix, Incorporated is a research and development stage bio-technology company. The Company is focused on the scientific medical research of anti-freeze glycoproteins (AFGPs) and anti-aging glycoproteins (AAGPs). The Company’s anti-aging glycopeptide is for the ophthalmology, dermatology, transplant support and biomanufacturing. The Company has not developed a commercially viable product and has not generated any revenue
Clarence Smith
Chairman of the Board, President, Chief Executive Officer
Michael Guzzetta
Chief Financial Officer
Address
412 Mulberry St
Marietta, OH
45750-2016
United States